Ligand Pharmaceuticals (LGND) Shares Outstanding (Entity) (2010 - 2026)

Ligand Pharmaceuticals (LGND) Shares Outstanding (Entity) (2010 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Shares Outstanding (Entity.) (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	254.16 Mn
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	147.69 Mn
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	200.18 Mn
10	Ligand Pharmaceuticals	6.05 Bn	5.27 Bn	48.45 Mn	20.03 Mn

Download Data